BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32452034)

  • 1. Volume effects in the TCP for hypoxic and oxygenated tumors.
    Chvetsov AV; Stewart RD; Kim M; Meyer J; Rengan R
    Med Phys; 2020 Sep; 47(9):4626-4633. PubMed ID: 32452034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Volume dependence in hypoxia-targeted dose escalation.
    Chvetsov AV; Zeng J; Rajendran JG
    Med Phys; 2018 Nov; 45(11):5325-5331. PubMed ID: 30192391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor control probability in hypofractionated radiotherapy as a function of total and hypoxic tumor volumes.
    Chvetsov AV; Hanin LG; Stewart RD; Zeng J; Rengan R; Lo SS
    Phys Med Biol; 2021 Jun; 66(12):. PubMed ID: 34030139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A modified hypoxia-based TCP model to investigate the clinical outcome of stereotactic hypofractionated regimes for early stage non-small-cell lung cancer (NSCLC).
    Strigari L; Benassi M; Sarnelli A; Polico R; D'Andrea M
    Med Phys; 2012 Jul; 39(7):4502-14. PubMed ID: 22830782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theoretical effectiveness of cell survival in fractionated radiotherapy with hypoxia-targeted dose escalation.
    Chvetsov AV; Rajendran JG; Zeng J; Patel SA; Bowen SR; Kim EY
    Med Phys; 2017 May; 44(5):1975-1982. PubMed ID: 28236652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of hypofractionation on simultaneous dose-boosting to hypoxic tumor subvolumes.
    Ruggieri R; Nahum AE
    Med Phys; 2006 Nov; 33(11):4044-55. PubMed ID: 17153384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of oxygen on intrinsic radiation sensitivity: A test of the relationship between aerobic and hypoxic linear-quadratic (LQ) model parameters.
    Carlson DJ; Stewart RD; Semenenko VA
    Med Phys; 2006 Sep; 33(9):3105-15. PubMed ID: 17022202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating the potential of proton therapy for hypoxia-targeted dose escalation in non-small cell lung cancer.
    Köthe A; Bizzocchi N; Safai S; Lomax AJ; Weber DC; Fattori G
    Radiat Oncol; 2021 Oct; 16(1):199. PubMed ID: 34635135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical oxygen enhancement ratio of tumors in carbon ion radiotherapy: the influence of local oxygenation changes.
    Antonovic L; Lindblom E; Dasu A; Bassler N; Furusawa Y; Toma-Dasu I
    J Radiat Res; 2014 Sep; 55(5):902-11. PubMed ID: 24728013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computed 88% TCP dose for SBRT of NSCLC from tumour hypoxia modelling.
    Ruggieri R; Stavreva N; Naccarato S; Stavrev P
    Phys Med Biol; 2013 Jul; 58(13):4611-20. PubMed ID: 23771131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal radiotherapy for prostate cancer: predictions for conventional external beam, IMRT, and brachytherapy from radiobiologic models.
    King CR; DiPetrillo TA; Wazer DE
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):165-72. PubMed ID: 10656389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: implications for the alpha/beta ratio.
    Nahum AE; Movsas B; Horwitz EM; Stobbe CC; Chapman JD
    Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):391-401. PubMed ID: 12957250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applying a hypoxia-incorporating TCP model to experimental data on rat sarcoma.
    Ruggieri R; Stavreva N; Naccarato S; Stavrev P
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1603-8. PubMed ID: 22270163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equivalent uniform aerobic dose in radiotherapy for hypoxic tumors.
    Chvetsov AV; Muzi M
    Phys Med Biol; 2024 Apr; 69(8):. PubMed ID: 38457839
    [No Abstract]   [Full Text] [Related]  

  • 15. A radiobiological model of reoxygenation and fractionation effects.
    Guerrero M; Carlson DJ
    Med Phys; 2017 May; 44(5):2002-2010. PubMed ID: 28273349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling tumor control probability for spatially inhomogeneous risk of failure based on clinical outcome data.
    Lühr A; Löck S; Jakobi A; Stützer K; Bandurska-Luque A; Vogelius IR; Enghardt W; Baumann M; Krause M
    Z Med Phys; 2017 Dec; 27(4):285-299. PubMed ID: 28676371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A voxel-based multiscale model to simulate the radiation response of hypoxic tumors.
    Espinoza I; Peschke P; Karger CP
    Med Phys; 2015 Jan; 42(1):90-102. PubMed ID: 25563250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Heterogeneous Cell Density in Hypoxic Tumors Treated with Radiotherapy.
    Schiavo F; Toma-Dasu I; Kjellsson Lindblom E
    Adv Exp Med Biol; 2023; 1438():121-126. PubMed ID: 37845450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of tumour control probability in hypoxic tumours by radiation dose redistribution: a modelling study.
    Søvik A; Malinen E; Bruland ØS; Bentzen SM; Olsen DR
    Phys Med Biol; 2007 Jan; 52(2):499-513. PubMed ID: 17202629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theoretical analysis of the dose dependence of the oxygen enhancement ratio and its relevance for clinical applications.
    Wenzl T; Wilkens JJ
    Radiat Oncol; 2011 Dec; 6():171. PubMed ID: 22172079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.